Home
About
Overview
Sharing Data
ORCID
Help
History (102)
Olmesartan Medoxomil
Hepatitis A
Coleoptera
G2 Phase
Efficacy of ALK5 inhibition in myelofibrosis.
See All 102 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Efficacy of ALK5 inhibition in myelofibrosis.
Efficacy of ALK5 inhibition in myelofibrosis. JCI Insight. 2017 04 06; 2(7):e90932.
View in:
PubMed
subject areas
Animals
Bone Marrow
Cell Differentiation
Cell Proliferation
Cells, Cultured
Collagen
HEK293 Cells
Hematopoietic Stem Cells
Humans
Janus Kinase 2
Male
Megakaryocytes
Mice
Mice, Inbred C57BL
Mice, Transgenic
Primary Myelofibrosis
Pyrazoles
Quinolines
Receptors, Thrombopoietin
Signal Transduction
Smad3 Protein
Transforming Growth Factor beta1
authors with profiles
Zhizhuang Joe Zhao